A recent study disclosed that FOXO1 supports inflammation during diabetes by increasing the expression of TLR4, recommending that FOXO1 may function as an essential regulator of inflammatory reactions during obesity and diabetes mellitus [116]. Here, FOXO1 is linked to obesity due to melanocortin 4 receptor deficiency.